Concepedia

Publication | Open Access

Severity of the <scp>TGN</scp>1412 trial disaster cytokine storm correlated with <scp>IL</scp>‐2 release

DOIFull Paper Access

56

Citations

33

References

2013

Year

David Eastwood, Chris Bird, Paula Dilger, Jason Hockley, Lucy Findlay, Stephen Poole, Susan J. Thorpe, Meenu Wadhwa, Robin Thorpe, Richard Stebbings
British Journal of Clinical Pharmacology

Abstract

The severity of the adverse response to TGN1412 compared with muromonab-CD3 and other therapeutic mAbs correlates with the level of IL-2 release.

References

YearCitations

Page 1